GLP 1's Germ Busting Gift: A New Layer in the Diabetes Treatment Puzzle Recent studies have linked GLP 1 medications, such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), to reduced risks of serious infections, including tuberculosis.
These findings challenge our understanding of diabetes treatment and raise questions about the potential long term benefits of GLP 1s.
One study published in Nature Communications examined the relationship between GLP 1 use and TB risk in people with type 2 diabetes.